#ES­MO21 is loom­ing, and we have a great group of ex­perts lined up to help make sense of the news

The one in­ter­na­tion­al sci­ence con­fer­ence I al­ways en­joyed at­tend­ing most has been ES­MO. You mix some high-oc­tane can­cer R&D news with one of the best col­lec­tion of glob­al ex­perts in the field. It was ed­u­ca­tion, break­ing news and a great Eu­ro­pean lo­ca­tion all built in­to one packed week­end.

AS­CO is great — but the ES­MO pack­age has been phe­nom­e­nal.

We’ve lost the lo­ca­tion, for now, but every­thing else is still in place for a big week­end. Man­ag­ing ed­i­tor Kyle Blanken­ship is lead­ing the cov­er­age on the news front, with the rest of the team pitch­ing in to help. And we’ll have the full line­up of sto­ries from the con­fer­ence in a spe­cial re­port on Mon­day, Sept. 20. Be sure to check it out. And fol­low us on Twit­ter through the week­end for break­ing news.

Endpoints Premium

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.